Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune System Activation via Enhanced Activation by Squalene-Based Adjuvant (N/A)
- Target
- N/A
- Molecular classification
- Adjuvant, Immunological enhancer
01
Overview
Squalene-based adjuvants are immunological enhancers that broadly activate the immune system, particularly in the context of vaccines. They function through DAMP signaling, increased APC recruitment and antigen presentation, and activation of both innate and adaptive immune arms, leading to stronger and broader B- and T-cell responses without a single molecular target or receptor. Key pathways involved include MyD88-dependent signaling, RIPK3-dependent necroptosis, and ASC/NLRP3-independent activation.
- Other names
- Squalene-based adjuvant effectAdjuvant-mediated immune enhancementMF59 adjuvantAS03 adjuvantAF03 adjuvant
02
Mechanism of action
Local DAMP release -> APC recruitment -> Antigen presentation -> Adaptive response
03
Biological functions
Innate immune activationAdaptive immune activationAntigen presentation enhancementCytokine productionChemokine productionB cell activationT cell activationInflammation
04
Disease associations
InfectionVaccine response enhancement
05
Safety considerations
Local injection site reactionsPotential for excessive inflammation (rare)
06
Interacting drugs
Influenza vaccines (MF59)
2 more in the full profile.
07
Biomarkers
Antibody titersT cell response magnitudeCytokine levels (IL-6, TNFα, G-CSF)
Beyond the preview
Go deeper on Immune System Activation via Enhanced Activation by Squalene-Based Adjuvant (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immune System Activation via Enhanced Activation by Squalene-Based Adjuvant (N/A).